CarboplatinEtoposideCisplatinAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelAntineoplastic AgentsPorcine epidemic diarrhea virusDrug Administration ScheduleLung NeoplasmsPlatinumOvarian NeoplasmsAntineoplastic Agents, PhytogenicCombined Modality TherapyCarcinoma, Small CellTreatment OutcomeCarcinoma, Non-Small-Cell LungInfusions, IntravenousThrombocytopeniaLeukopeniaDoxorubicinDrug Resistance, NeoplasmDisease-Free SurvivalSurvival AnalysisCyclophosphamideDose-Response Relationship, DrugDeoxycytidineNeutropeniaVinblastineSurvival RateGerminomaVincristineTesticular NeoplasmsHematologic DiseasesNeoplasm StagingArea Under CurveDrug EvaluationMaximum Tolerated DoseNeoplasms, Germ Cell and EmbryonalTopoisomerase II InhibitorsOrganoplatinum CompoundsBleomycinTaxoidsRemission InductionThiotepaNeoplasmsDrug SynergismDrug Screening Assays, AntitumorCamptothecinRetinal NeoplasmsNeoplasm Recurrence, LocalVomitingCell Line, TumorAmifostineNauseaPodophyllotoxinTopotecanApoptosisDNA AdductsSalvage TherapyDNA Topoisomerases, Type IIFallopian Tube NeoplasmsSeminomaFluorouracilRetinoblastomaHead and Neck NeoplasmsTumor Cells, CulturedPeritoneal NeoplasmsCarcinoma, Squamous CellTransplantation, AutologousTeniposideDNA DamageCell SurvivalMesnaCarcinomaAdenocarcinomaAlopeciaGuanineChemotherapy, AdjuvantFeasibility StudiesDrug HypersensitivityDrug ResistanceMelphalanAmsacrineNalbuphineBone Marrow DiseasesEpirubicinNeoplasms, Unknown PrimaryGranulocyte Colony-Stimulating FactorAdministration, OralRetroperitoneal NeoplasmsSmall Cell Lung CarcinomaGlutamatesPlatinum CompoundsAntineoplastic Agents, AlkylatingMitoxantroneNeoplasm MetastasisUrologic NeoplasmsPrognosisCarmustineTime Factors